New salicylates as maintenance treatment in ulcerative colitis (Q43215188)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 1994

edit

Language	Label	Description	Also known as
English	New salicylates as maintenance treatment in ulcerative colitis	scientific article published in September 1994

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

1375685

retrieved

16 November 2017

title

New salicylates as maintenance treatment in ulcerative colitis (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

1375685

retrieved

16 November 2017

author name string

Järnerot G

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

1375685

retrieved

16 November 2017

language of work or name

English

0 references

publication date

1 September 1994

1 reference

stated in

Europe PubMed Central

PMC publication ID

1375685

retrieved

16 November 2017

published in

Gut

1 reference

stated in

Europe PubMed Central

PMC publication ID

1375685

retrieved

16 November 2017

volume

35

1 reference

stated in

Europe PubMed Central

PMC publication ID

1375685

retrieved

16 November 2017

issue

9

1 reference

stated in

Europe PubMed Central

PMC publication ID

1375685

retrieved

16 November 2017

page(s)

1155-1158

1 reference

stated in

Europe PubMed Central

PMC publication ID

1375685

retrieved

16 November 2017

cites work

Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Clinical tolerance of olsalazine.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double-blind comparison with sulphasalazine.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Gastric emptying of indigestible tablets in relation to composition and time of ingestion of meals studied by metal detector

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Sulphasalazine induced renal failure

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis. The Danish Olsalazine Study Group

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

25 May 2018

Nephrotoxic lesions from 5-aminosalicylic Acid.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

15 August 2018

Olsalazine in maintenance of clinical remission in patients with ulcerative colitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1375685

retrieved

15 August 2018

Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7959217

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7959217

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7959217

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7959217

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved maintenance of remission in ulcerative colitis by balsalazide 4 g/day compared with 2 g/day

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7959217

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7959217

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7959217

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7959217

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short report: comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7959217

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7959217

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7959217

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

pH profile of gut as measured by radiotelemetry capsule

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7959217

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption and excretion of a single 1-g dose of azodisal sodium in subjects with ileostomy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7959217

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1136/GUT.35.9.1155

1 reference

stated in

Europe PubMed Central

PMC publication ID

1375685

retrieved

16 November 2017

PMC publication ID

1375685

1 reference

stated in

Europe PubMed Central

PMC publication ID

1375685

retrieved

16 November 2017

PubMed publication ID

7959217

1 reference

stated in

Europe PubMed Central

PMC publication ID

1375685

retrieved

16 November 2017

ResearchGate publication ID

15240456

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43215188&oldid=1983952458"